KEY FEATURES
| Full Name | Transferrin Receptor 2 |
|---|---|
| Synonym | HFE3; TFRC2 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.62-40ng/mL |
| Sensitivity | 0.27ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human TFR2 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human TFR2. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human TFR2 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human TFR2, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human TFR2. You can calculate the concentration of Human TFR2 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human TFR2 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.86 | 4.89 | 18.83 | 1.71 | 5.25 | 17.07 |
| Standard deviation | 0.09 | 0.26 | 0.66 | 0.12 | 0.23 | 0.7 |
| CV(%) | 5.06 | 5.41 | 3.48 | 6.98 | 4.35 | 4.12 |
RECOVERY
The recovery of Human TFR2 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 92-105 | 97 |
| EDTA plasma (n=8) | 94-110 | 101 |
| Cell culture media (n=8) | 89-104 | 96 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human TFR2 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with TFR ELISA Kits
| HFE ELISA Kit | publications with TFR and HFE |
| HAMP ELISA Kit | publications with TFR and HAMP |
| SLC40A1 ELISA Kit | publications with TFR and SLC40A1 |
| TMPRSS6 ELISA Kit | publications with TFR and TMPRSS6 |
| EPOR ELISA Kit | publications with TFR and EPOR |
| HEPH ELISA Kit | publications with TFR and HEPH |
| CYBRD1 ELISA Kit | publications with TFR and CYBRD1 |
| SLC11A2 ELISA Kit | publications with TFR and SLC11A2 |
Pathways associated with TFR ELISA Kit
| Iron Metabolism In Placenta Pathway | Iron Metabolism In Placenta Pathway |
Diseases associated with TFR ELISA Kit
| Hemochromatosis | publications with TFR and Hemochromatosis |
| Anemia | publications with TFR and Anemia |
| Liver Diseases | publications with TFR and Liver Diseases |
| Inflammation | publications with TFR and Inflammation |
| Disease Models, Animal | publications with TFR and Disease Models, Animal |
| Carcinoma, Hepatocellular | publications with TFR and Carcinoma, Hepatocellular |
| Liver Neoplasms | publications with TFR and Liver Neoplasms |
| beta-Thalassemia | publications with TFR and beta-Thalassemia |
| Fibrosis | publications with TFR and Fibrosis |
| Nervous System Diseases | publications with TFR and Nervous System Diseases |
Organs/Tissues associated with TFR ELISA Kit
| Liver | publications with TFR and Liver |
| Bone | publications with TFR and Bone |
| Brain | publications with TFR and Brain |
| Bone Marrow | publications with TFR and Bone Marrow |
| Lung | publications with TFR and Lung |
| Lymph Node | publications with TFR and Lymph Node |
| Uncharacterized Tissue | publications with TFR and Uncharacterized Tissue |
| Connective Tissue | publications with TFR and Connective Tissue |